Drug Shortage Report for HEPARIN SODIUM INJECTION, USP
| Report ID | 168106 |
| Drug Identification Number | 02264315 |
| Brand name | HEPARIN SODIUM INJECTION, USP |
| Common or Proper name | HEPARIN SODIUM INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPARIN SODIUM |
| Strength(s) | 1000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 1 mL |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-01 |
| Estimated end date | 2022-09-15 |
| Actual end date | 2022-09-13 |
| Shortage status | Resolved |
| Updated date | 2022-09-14 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be facing a supply interruption on our Heparin Sodium Injection, USP 1 000 USP units/mL MD Vial 1 mL and Heparin Sodium Injection, USP 1 000 USP units/mL MD Vial 30 mL effective September 1, 2022 until September 15, 2022. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-09-14 | English | Compare |
| v5 | 2022-09-12 | French | Compare |
| v4 | 2022-09-12 | English | Compare |
| v3 | 2022-09-02 | English | Compare |
| v2 | 2022-08-29 | French | Compare |
| v1 | 2022-08-29 | English | Compare |
Showing 1 to 6 of 6